This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Satoko Yamashita: Innovator in Diabetes Treatment
Introduction
Satoko Yamashita is a prominent inventor based in Nagoya, Japan. She has made significant contributions to the field of medicine, particularly in the treatment of type 2 diabetes. Her innovative approach combines existing diabetic medications with new compounds to enhance treatment efficacy.
Latest Patents
Yamashita holds a patent for a medicine that consists of the concomitant use or combination of a DPP-IV inhibitor and other diabetic medicines. The problem addressed by her invention is to provide a medicine that is effective in treating type 2 diabetes, diabetic complications, or impaired glucose tolerance. The patent describes a medicine characterized by a compound represented by a specific general formula, along with at least one other diabetic medicine.
Career Highlights
Yamashita is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where she has been instrumental in advancing research and development in diabetes treatment. Her work has garnered attention for its potential to improve patient outcomes in managing diabetes.
Collaborations
Yamashita has collaborated with notable colleagues, including Moritaka Goto and Keizo Nakaya. These partnerships have contributed to the success of her research and the development of innovative medical solutions.
Conclusion
Satoko Yamashita's contributions to diabetes treatment through her innovative patent highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in diabetes management and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile